HK1257585A1 - 預防和治療皮膚纖維化的藥物及其用途 - Google Patents

預防和治療皮膚纖維化的藥物及其用途

Info

Publication number
HK1257585A1
HK1257585A1 HK18116704.3A HK18116704A HK1257585A1 HK 1257585 A1 HK1257585 A1 HK 1257585A1 HK 18116704 A HK18116704 A HK 18116704A HK 1257585 A1 HK1257585 A1 HK 1257585A1
Authority
HK
Hong Kong
Prior art keywords
medicine
preventing
treating skin
skin fibrosis
fibrosis
Prior art date
Application number
HK18116704.3A
Other languages
English (en)
Inventor
李季男
Original Assignee
深圳瑞健生命科學研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳瑞健生命科學研究院有限公司 filed Critical 深圳瑞健生命科學研究院有限公司
Publication of HK1257585A1 publication Critical patent/HK1257585A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18116704.3A 2016-12-15 2018-12-28 預防和治療皮膚纖維化的藥物及其用途 HK1257585A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611162270 2016-12-15

Publications (1)

Publication Number Publication Date
HK1257585A1 true HK1257585A1 (zh) 2019-10-25

Family

ID=62656674

Family Applications (5)

Application Number Title Priority Date Filing Date
HK18116707.0A HK1257588A1 (zh) 2016-12-15 2018-12-28 預防和治療肺纖維化的藥物及其用途
HK18116703.4A HK1257584A1 (zh) 2016-12-15 2018-12-28 預防和治療系統性硬化症的藥物及其用途
HK18116704.3A HK1257585A1 (zh) 2016-12-15 2018-12-28 預防和治療皮膚纖維化的藥物及其用途
HK18116708.9A HK1257589A1 (zh) 2016-12-15 2018-12-28 預防和治療組織器官纖維化的藥物及其用途
HK18116706.1A HK1257587A1 (zh) 2016-12-15 2018-12-28 預防和治療肝纖維化的藥物及其用途

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HK18116707.0A HK1257588A1 (zh) 2016-12-15 2018-12-28 預防和治療肺纖維化的藥物及其用途
HK18116703.4A HK1257584A1 (zh) 2016-12-15 2018-12-28 預防和治療系統性硬化症的藥物及其用途

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK18116708.9A HK1257589A1 (zh) 2016-12-15 2018-12-28 預防和治療組織器官纖維化的藥物及其用途
HK18116706.1A HK1257587A1 (zh) 2016-12-15 2018-12-28 預防和治療肝纖維化的藥物及其用途

Country Status (2)

Country Link
CN (5) CN108210892A (zh)
HK (5) HK1257588A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110917335B (zh) * 2018-09-20 2023-06-27 华中科技大学同济医学院附属同济医院 Erdr1在预防和治疗纤维化疾病中的用途
CN115427066A (zh) * 2020-02-06 2022-12-02 泰伦基国际有限公司 一种预防和治疗多发性硬化症的方法和药物
CA3169325A1 (en) * 2020-02-26 2021-09-02 Jinan Li Method and drug for preventing and treating abnormal blood pressure condition
CN113925022A (zh) * 2021-10-22 2022-01-14 莫汉有 一种系统性红斑狼疮并动脉粥样硬化动物模型构建方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA00011713A (es) * 2000-11-28 2002-05-31 Tgt Lab S A De C V Vectores recombinantes virales y no virales conteniendo el gen humano del activador de plasminogeno derivado de urocinasa y su utilidad en el tratamiento de diversos tipos de fibrosis hepatica, renal, pulmonar, pancreatica, cardiaca y cicatrices hipe
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
US20050250694A1 (en) * 2003-10-10 2005-11-10 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
AU2008331545B2 (en) * 2007-11-29 2014-01-16 Grifols Therapeutics Inc. Recombinantly modified plasmin
KR20120050442A (ko) * 2009-07-10 2012-05-18 쓰롬보제닉스 엔.브이. 플라스미노겐 및 플라스민의 변이체
CN101628113B (zh) * 2009-08-18 2012-01-04 南京农业大学 蚯蚓纤溶酶抗肝纤维化的应用
WO2011139974A2 (en) * 2010-05-03 2011-11-10 Abbott Laboratories Anti-pai-1 antibodies and methods of use thereof
US9655973B2 (en) * 2012-03-09 2017-05-23 Vascular Biosciences Orally active, cell-penetrating homing peptide and methods of using same
KR101467109B1 (ko) * 2013-07-10 2014-12-01 영남대학교 산학협력단 Ｂｉｘ02189 화합물을 유효성분으로 포함하는 폐섬유증 예방 또는 치료용 조성물
EA033403B1 (ru) * 2013-08-13 2019-10-31 Sanofi Sa Антитела к ингибитору активатора плазминогена 1 (pai-1) и пути их применения
TW201734054A (zh) * 2013-08-13 2017-10-01 賽諾菲公司 胞漿素原活化素抑制劑-１（ｐａｉ-１）之抗體及其用途
WO2015026494A2 (en) * 2013-08-20 2015-02-26 Trustees Of Dartmouth College Methods for treating tissue fibrosis

Also Published As

Publication number Publication date
HK1257587A1 (zh) 2019-10-25
HK1257589A1 (zh) 2019-10-25
HK1257584A1 (zh) 2019-10-25
HK1257588A1 (zh) 2019-10-25
CN108210910A (zh) 2018-06-29
CN108210897A (zh) 2018-06-29
CN108210892A (zh) 2018-06-29
CN108210905A (zh) 2018-06-29
CN108210899A (zh) 2018-06-29

Similar Documents

Publication Publication Date Title
IL277648A (en) Medical microbiota for the treatment and/or prevention of food allergy
IL249189A0 (en) Combined treatment of antibodies against human cd40 and antibodies against human pd-l1
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
IL260771B1 (en) Catheter closure solution and catheter closure treatment
HK1257321A1 (zh) 用於治療腦組織的組織摧毀術治療系統和方法
IL265955A (en) Therapeutic compounds and methods of use thereof
ZA201901055B (en) Treatment and prevention of sleep disorders
ZA201704726B (en) Peptides and their use in the treatment of skin
HK1257585A1 (zh) 預防和治療皮膚纖維化的藥物及其用途
HK1247963A1 (zh) 用於hiv的治療的基因療法及其用途
HK1257236A1 (zh) 預防和治療高脂血症的藥物及其用途
GB201617064D0 (en) Compounds and their therapeutic use
IL281585B (en) Selenogalactoside compounds for the prevention and treatment of galectin-related diseases and their use
EP3169321A4 (en) Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health
GB201715194D0 (en) Compounds and their therapeutic use
IL272121A (en) Preparation and methods for the treatment of myopia
GB201504387D0 (en) Materials and methods for the treatment of vascular disease
GB201710822D0 (en) Methods and medical uses relating to the treatment of hypoglycaemia
EP3723742C0 (fr) Utilisation de la fluoroethylnormemantine pour la prevention et le traitement de l'anxiete
HK1257586A1 (zh) 預防和治療腎纖維化的藥物及其用途
HK1257238A1 (zh) 預防和治療脂質腎損傷的藥物及其用途
EP3609578A4 (en) PHARMACEUTICAL COMBINATION AND ITS USE FOR THE TREATMENT OF SYNUCLEINOPATHIES
HK1252359A1 (zh) 用於治療疼痛的曲唑酮和加巴噴丁的組合
HUE054888T2 (hu) Készítmény a fejbõr és bõr kiégés szindrómájának terápiájára és megelõzésére